ArticleFrontiers in endocrinology2026
Association between impaired peripheral thyroid hormone sensitivity and coronary heart disease in type 2 diabetes: the potential mediating role of albumin.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes mellitus (T2DM) is associated with a high risk of cardiovascular mortality, primarily from coronary heart disease (CHD). Thyroid hormone (TH) sensitivity and albumin independently influence cardiovascular health and metabolic homeostasis. However, the potential mediating role of albumin in the association between TH sensitivity and the risk of CHD remains unclear in patients with T2DM. Methods: This cross-sectional study enrolled 430 hospitalized T2DM patients, categorized into CHD and non-CHD groups. Central TH sensitivity was evaluated using the thyrotrophic thyroxine resistance index (TT4RI), thyroid-stimulating hormone index (TSHI), thyroid feedback quantile index (TFQI), and parametric thyroid feedback quantile index (PTFQI). Peripheral TH sensitivity was estimated by the free triiodothyronine to free thyroxine (FT3/FT4) ratio. Logistic regression, restricted cubic spline and receiver operating characteristic curve were performed. Mediation analysis quantified the indirect effects of serum albumin. Results: Compared to non-CHD patients, the CHD group exhibited significantly diminished FT3/FT4 ratio and albumin levels. Multivariate logistic regression indicated that a decreased FT3/FT4 ratio was independently associated with CHD, whereas central TH sensitivity indices showed no significant correlation. The FT3/FT4 ratio exhibited the modest discriminative ability for CHD (AUC = 0.740). Furthermore, albumin partially mediated the association between peripheral TH sensitivity and CHD, accounting for 19.3% of the total effect. Conclusions: Impaired peripheral thyroid hormone sensitivity is positively associated with CHD in T2DM and serum albumin might be one of its biological mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.